Terlipressin or Europressin?
-
Correspondence: Marc Leone marc.leone@ap-hm.fr
Service d'anesthésie et de réanimation, Hôpital Nord, Chemin des Bourrely, 13915 Marseille cedex 20 France
Critical Care 2009, 13:192 doi:10.1186/cc8035
Published: 7 October 2009Abstract
Use of terlipressin in septic shock relies on a series of European studies resulting in a better knowledge of this vasopressive agent. Additional studies demonstrate that this agent appears to have attractive properties when administered properly. In comparison to prior reports, continuous infusion of low-dose terlipressin seems superior when administered to septic animals. For the first time in humans, Morelli and colleagues compared this mode of administration with other vasopressors.